Table 2.
Results
| |
Misoprostol |
Surgical |
RR(95% CI) / p-value |
|---|---|---|---|
| n = 465 | n = 374 | ||
| Success: % (n)a |
|
|
|
| Complete abortion |
94.4 (439) |
100.0 (374) |
0.90 (0.88-0.92) |
| Incomplete abortion/ongoing pregnancy |
5.6 (26) |
0.0 (0) |
|
| Success by site |
|
|
|
| Senegal |
92.9 (92/99) |
100.0 (100/100) |
0.89 (0.84-0.94) |
| Niger |
88.7 (63/71) |
100.0 (81/81) |
0.85 (0.78-0.92) |
| Mauritania |
91.4 (53/58) |
100.0 (61/61) |
0.87 (0.81-0.94) |
| Nigeria |
96.2 (25/26) |
100.0 (25/25) |
0.92 (0.85-0.99) |
| Burkina Faso |
97.6 (206/211) |
100.0 (107/107) |
0.97 (0.97-0.97) |
| Ultrasound used to evaluate successb: % (n) |
39.1 (167/427) |
17.8 (60/338) |
p < 0.001 |
| Senegalc |
81.1 (77/95) |
18.6 (16/86) |
p < 0.001 |
| Other 4 sites |
27.1 (90/332) |
17.5 (44/252) |
p < 0.01 |
| Women who made an unscheduled visitd |
2.9 (13/452) |
1.1 (4/366) |
p = 0.14 |
| Women who called the providere | 6.0 (27/448) | 1.1 (4/364) | p < 0.01 |
a21 women from the Niger site were lost to follow-up: 15 in the misoprostol arm and 6 in the surgical arm.
bUltrasound data is not available for 74 women: 38 in the misoprostol arm and 36 in the surgical arm.
cSenegal was required by their IRB to use ultrasound in evaluating outcome.
d3 women in the misoprostol arm made 2 unscheduled visits; all others made only 1 unscheduled visit.
e4 women in the misoprostol arm called twice; all other callers called once.